Ardelyx Financial Ratios
NASDAQ: ARDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ardelyx ratio analysis
Ardelyx earned a net margin of -15.1% in FY 2025, down from -11.7% a year earlier. Gross margin was 90.3% compared with a median of 87.2% over the prior 8 years. Return on equity reached -36.9%, meaning Ardelyx generated -0.37 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 1.21 versus 0.87 the year before, and the current ratio was 4.31. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Ardelyx financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Price / sales | 3.64 | 3.50 | 10.93 | 8.67 | 11.35 | 76.55 | 88.40 | 44.42 | 7.45 | — |
| Price / book | 8.88 | 6.75 | 8.15 | 4.60 | 1.39 | 4.60 | 2.50 | 1.00 | 2.25 | 2.95 |
| Gross margin | 90.3% | 84.8% | 85.7% | 92.1% | 90.1% | 98.1% | 88.6% | 82.1% | 80.0% | — |
| Operating margin | -10.1% | -8.4% | -50.8% | -122.2% | -1,528.6% | -1,199.0% | -1,728.1% | -3,488.6% | -155.0% | — |
| Net margin | -15.1% | -11.7% | -53.1% | -128.9% | -1,566.5% | -1,245.7% | -1,797.8% | -3,502.0% | -153.2% | — |
| Free cash flow margin | -10.8% | -13.7% | -72.4% | -134.4% | -1,529.3% | -1,079.9% | -1,454.4% | -2,707.5% | -160.8% | — |
| Return on equity (ROE) | -36.9% | -22.6% | -39.6% | -68.3% | -191.4% | -74.8% | -50.9% | -78.8% | -46.2% | -58.2% |
| Return on assets (ROA) | -12.3% | -9.0% | -22.2% | -35.4% | -105.5% | -46.8% | -36.5% | -49.8% | -40.7% | -52.7% |
| Debt / equity | 1.21 | 0.87 | 0.30 | 0.27 | 0.78 | 0.40 | 0.27 | 0.45 | — | — |
| Current ratio | 4.31 | 4.58 | 4.88 | 2.34 | 2.53 | 6.85 | 11.34 | 9.95 | 8.38 | 10.62 |
| Revenue growth | 22.1% | 168.1% | 138.6% | 416.6% | 33.4% | 43.4% | 102.6% | -93.8% | — | — |